Glenmark Pharmaceuticals S.a.

Glenmark Pharmaceuticals Limited

Shailesh Shrirang Pawase

Suresh Mahadev Kadam

Sachin Baban Gavhane

Abraham Thomas

Shekhar Bhaskar Bhirud

Sukeerthi Kumar

Sukumar Sinha

Bipin Parsottam Kansagra

Sandeep Bandu Khandagale

Jayant Prakashrao Patil

Shailendra Nilkanth Bhadane

Rajesh Kumar Dwivedi

Aniket Ashokrao Deshpande

Anil Subhash Bhujbal

Bhavna Mishra

Provided is an improved process for the preparation of arformoterol L-(+)-tartrate, and more specifically provided is a novel process for the preparation of arformoterol L-(+)-tartrate via arformoterol D-(&#x2212;)-tartrate.

Process for the preparation of arformoterol or salt thereof

The present disclosure is directed to salts of N-{4-[2,4-difluoro-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl}dimethyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-5-yl)acetamide and process for the preparation thereof (formula II). 

Amides of 2-amino-4-arylthiazole compounds and their salts

Growing community of inventors

Mumbai, India

Shailesh Shrirang Pawase